Ultimately, this policy change would mean Internal Revenue Code 280E would no longer apply to cannabis businesses, meaning ...
Zacks Investment Research on MSN
TLRY vs. CGC: Which cannabis stock is the better investment now?
The global cannabis market is rapidly evolving, with President Trump’s decision to federally reschedule marijuana in the ...
Green Thumb expects to generate significantly more free cash flow due to marijuana's rescheduling.
The cannabis sector is one which many may have rightly described as a bubble seven or eight years ago. That’s because it was.
Much of its tailwinds are attributed to the US President Donald Trump finally signing "an executive order to classify ...
YOLO offers global cannabis sector exposure with an actively managed, low-fee structure and $40M in net assets. Learn more ...
Beacon Securities analyst Russell Stanley has maintained a “Buy” rating and C$5.00 price target on Curaleaf Holdings ...
Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora Cannabis are two leaders in the Canadian market that could turn their attention ...
The Washington Post reports that President Trump will reschedule marijuana as a Schedule III drug. Marijuana is already legal in Canada, but Aurora Cannabis can't seem to make a profit off of it.
Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived ...
Shares of Aurora Cannabis Inc. ACB slipped 3.24% to $4.18 Thursday, on what proved to be an all-around mixed trading session ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results